| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/05/2002 | US6352986 Treatments for nervous disorders |
| 03/05/2002 | US6352985 Benzimidazole compounds |
| 03/05/2002 | US6352984 For treatment of psychological disorders, schizophrenia |
| 03/05/2002 | US6352983 Antibiotics and bactericides |
| 03/05/2002 | US6352981 Treat disorders which respond to dopamine d.sub.3 ligands such as schistosomiasis, schizophrenia, depression, neuroses or psychoses |
| 03/05/2002 | US6352979 Method of treating snakebite and complications resulting therefrom |
| 03/05/2002 | US6352978 Pharmaceutical compositions containing tobramycin and xanthan gum |
| 03/05/2002 | US6352970 Treatment of skeletal disorders |
| 03/05/2002 | US6352844 Ceramide generating retinoids and inhibitors of tumors |
| 03/05/2002 | US6352839 Preparing virginiamycins from an engineered microorganisms, having the ability to prevent biosynthesis of the precursor antibiotic; the microorganism is cultured in the presence of a second precursor and the streptogramin analog is recovered |
| 03/05/2002 | US6352737 Use of nanoscale sterols and sterol esters |
| 03/05/2002 | US6352728 Reduced gastric irritation by administering non-steroidal antiinflammatory agent |
| 03/05/2002 | US6352727 Bactericides |
| 03/05/2002 | US6352722 Time-release agent comprising trehalose diisobutyrate hexaacetate and fluticasone; drug delivery |
| 03/05/2002 | US6352720 Tablet with extra-granular disintegrant; administering orally to treat bacterial infections |
| 03/05/2002 | US6352715 Sheet of drug-impermeable backing laminate supports huperzine a dispersing pressure sensitive adhesive |
| 03/05/2002 | US6352709 Introducing into patient a medical device of which at least a portion comprises one of a sydnonimine and a furoxan; anticoagulants |
| 03/05/2002 | US6352701 Stable hydroalcoholic compositions |
| 03/05/2002 | US6352698 Free radical scavenger, antiallergen, and antiinflammatory agents |
| 03/05/2002 | US6352692 Lipase inhibiting polymers |
| 03/05/2002 | US6352686 Antipsoriatic nail polish |
| 03/05/2002 | US6352685 External preparation for skin |
| 03/05/2002 | US6352682 Polymeric delivery of radionuclides and radiopharmaceuticals |
| 03/05/2002 | CA2272138C Pyrazolopyrimidine and pyrazolopyridine compounds having crf antagonist activity |
| 03/05/2002 | CA2266565C Azabicyclic rotomase inhibitors |
| 03/05/2002 | CA2215013C N-substituted indol-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action |
| 03/05/2002 | CA2209892C Methods and pharmaceutical compositions employing desmethylselegiline |
| 03/05/2002 | CA2207574C Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products |
| 03/05/2002 | CA2206122C Arylacrylamide derivatives |
| 03/05/2002 | CA2145290C Methods and compositions for controlling translation of hcv proteins |
| 03/05/2002 | CA2126465C Inhibitor for restenosis after percutaneous coronary arterioplasty |
| 03/05/2002 | CA2111955C Novel tetracyclic compound |
| 03/05/2002 | CA2098735C Novel methylenebisphosphonic acid derivatives |
| 03/05/2002 | CA2098732C Novel methylenebisphosphonic acid derivatives |
| 03/05/2002 | CA2081269C Penetration enhancement of topically applied formulations |
| 03/05/2002 | CA2056638C 2 .beta., 19-ethylene bridged steroids as aromatase inhibitors |
| 03/05/2002 | CA2051531C Superior tasting pharmaceutical composition having porous particles and the process of preparing such pharmaceutical composition |
| 03/05/2002 | CA2049850C 4-substituted dihydropyrido[4,3-d]pyrimidines as analgesics and topical antiinflammatory agents for the treatment of skin disorders |
| 02/28/2002 | WO2002016636A2 Diagnostic and therapeutic use of a caveolae-associated integral membrane protein for alzheimer's disease and related neurodegenerative disorders |
| 02/28/2002 | WO2002016620A2 Modulation of stem cell differentiation |
| 02/28/2002 | WO2002016611A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 02/28/2002 | WO2002016608A1 New sequences |
| 02/28/2002 | WO2002016602A2 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | WO2002016575A1 METHOD OF SCREENING FOR INHIBITORS OF HUMAN FATTY ACID-CoA LIGASE 4 |
| 02/28/2002 | WO2002016395A1 Prodrugs of betulinic acid derivatives for the treatment of cancer and hiv |
| 02/28/2002 | WO2002016394A1 Thioether-sulphamate steroids as steroid sulphatase inhibitors and anti-cancer compounds |
| 02/28/2002 | WO2002016393A1 17-aryl-linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase |
| 02/28/2002 | WO2002016392A1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 02/28/2002 | WO2002016382A1 Improved specificity in treatment of diseases |
| 02/28/2002 | WO2002016381A2 Composition and method for inhibiting platelet aggregation |
| 02/28/2002 | WO2002016380A1 New macrolides with antibacterial activity |
| 02/28/2002 | WO2002016376A1 Thermosensitive cyclotriphosphazene-platinum complex conjugate, its preparation method and anticancer agent containing the same |
| 02/28/2002 | WO2002016368A1 Process for the preparation and purification of thiol-containing maytansinoids |
| 02/28/2002 | WO2002016365A1 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity |
| 02/28/2002 | WO2002016359A1 Fused pyrazole derivatives being protein kinase inhibitors |
| 02/28/2002 | WO2002016358A2 Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands) |
| 02/28/2002 | WO2002016357A2 Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands) |
| 02/28/2002 | WO2002016355A2 Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic) acetylcholine receptor ligands |
| 02/28/2002 | WO2002016353A1 Bicyclic heteroaromatic derivatives for the treatment of immune and inflammatory disorders |
| 02/28/2002 | WO2002016352A1 Quinazoline derivatives |
| 02/28/2002 | WO2002016351A1 Quinazoline derivatives as kinase inhibitors |
| 02/28/2002 | WO2002016349A1 4-, 5-, 6- and 7-indole derivatives useful for the treatment of cns disorders |
| 02/28/2002 | WO2002016348A1 Antiangiogenic bicyclic derivatives |
| 02/28/2002 | WO2002016347A1 Active metabolite of gepirone |
| 02/28/2002 | WO2002016342A1 Method for the preparation of citalopram |
| 02/28/2002 | WO2002016341A1 Method for the preparation of citalopram |
| 02/28/2002 | WO2002016340A1 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 02/28/2002 | WO2002016339A1 Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 02/28/2002 | WO2002016338A1 Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 02/28/2002 | WO2002016337A1 Tricyclic compounds and pharmaceutical compositions containing the same |
| 02/28/2002 | WO2002016333A2 Thioflavin derivatives and their use in diagnosis and theraphy of alzheimer's disease |
| 02/28/2002 | WO2002016332A1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists |
| 02/28/2002 | WO2002016331A1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists |
| 02/28/2002 | WO2002016326A1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases |
| 02/28/2002 | WO2002016325A1 Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of same |
| 02/28/2002 | WO2002016324A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 02/28/2002 | WO2002016321A1 Prodrugs to nmda receptor ligands |
| 02/28/2002 | WO2002016319A1 Novel thiourea compounds and the pharmaceutical compositions containing the same |
| 02/28/2002 | WO2002016318A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 02/28/2002 | WO2002016317A1 Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same |
| 02/28/2002 | WO2002016316A1 10-ARYL-11-HBENZO [b]FLUORENE DERIVATIVES AND ANALOGS FOR MEDICINAL USE |
| 02/28/2002 | WO2002016315A1 Aza-amino acid derivatives (factor xa-inhibitors 15) |
| 02/28/2002 | WO2002016313A2 Integrin receptor inhibitors |
| 02/28/2002 | WO2002016310A1 Selective androgen receptor modulators and methods of use thereof |
| 02/28/2002 | WO2002016309A1 Compounds and compositions for delivering active agents |
| 02/28/2002 | WO2002015959A2 Compounds and compositions for delivering active agents |
| 02/28/2002 | WO2002015942A1 Method for the identification of agents that inhibit or promote cataracts and uses thereof |
| 02/28/2002 | WO2002015941A1 A method for reducing stress-induced overproduction of neuropeptide y in an individual |
| 02/28/2002 | WO2002015940A2 Solution of an oxazolidinone antibiotic drug |
| 02/28/2002 | WO2002015938A2 Testosterone ester formulation for human use |
| 02/28/2002 | WO2002015937A2 Pharmaceutical composition for the systematic administration of pharmacologically active ingredients containing polyol fatty acid esters |
| 02/28/2002 | WO2002015936A1 Antifungal ketoconazole composition for topical use |
| 02/28/2002 | WO2002015935A1 Fibrinogen lowering agents |
| 02/28/2002 | WO2002015934A1 Preventives and remedies for central nervous system diseases |
| 02/28/2002 | WO2002015933A2 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser |
| 02/28/2002 | WO2002015922A2 New uses for amino acid anticonvulsants for treatment of pain |
| 02/28/2002 | WO2002015920A2 Treatment of hyperproliferative diseases |
| 02/28/2002 | WO2002015913A1 Treatment of trauma, and other indications |
| 02/28/2002 | WO2002015912A1 Compounds and methods for inhibiting neuronal cell death |
| 02/28/2002 | WO2002015910A1 2-substituted estradiol derivative for inhibiting superoxid dismutase |